NFκB in the development of endothelial activation and damage in uremia: an in vitro approach

Area of Science:

• Nephrology
• Vascular Biology
• Biochemistry

Background:

• Chronic kidney disease (CKD) is linked to impaired hemostasis and accelerated atherosclerosis.
• Endothelial dysfunction is a key factor in atherothrombotic events in CKD patients.
• The specific impact of renal replacement therapies on endothelial health is often overlooked.

Purpose of the Study:

• To evaluate plasma markers of endothelial activation and damage in CKD patients across different treatment modalities.
• To assess the activation of p38 MAPK and NFκB in endothelial cells exposed to uremic sera and dialysis fluids.
• To compare the pro-inflammatory effects of conservative treatment, hemodialysis, and peritoneal dialysis on the endothelium.

Main Methods:

• Measured plasma markers (VCAM-1, ICAM-1, VWF, circulating endothelial cells) in controls and CKD patients (predialysis, hemodialysis, peritoneal dialysis).
• Exposed endothelial cell cultures to pooled sera and peritoneal dialysis fluids.
• Assessed activation of p38 MAPK and NFκB signaling pathways.

Main Results:

• CKD patients exhibited significantly higher levels of endothelial activation markers compared to controls.
• Peritoneal dialysis patients showed the most pronounced increase in these markers.
• Exposure to sera and peritoneal dialysis fluids correlated with increased p38 MAPK and NFκB activation in endothelial cells.
• Hemodialysis did not exacerbate endothelial damage beyond the uremic state, suggesting improved biocompatibility.

Conclusions:

• Peritoneal dialysis may exert a significant pro-inflammatory effect on the endothelium, potentially due to high glucose and degradation products in dialysis fluid.
• Hemodialysis appears to have a lower inflammatory impact compared to peritoneal dialysis in recent years.
• Findings challenge the notion of peritoneal dialysis as a purely physiological technique regarding endothelial inflammation and damage.